Melissa Copland
Melissa Copland is the clinical lead of medicines management at Pharmac, New Zealand's pharmaceutical management agency. She recently confirmed the funding of desogestrel, branded as Cerazette, which will be available from April 1 for individuals needing treatment for endometriosis. This decision is expected to benefit over 43,000 New Zealanders and aims to improve access to effective treatment for those suffering from the debilitating symptoms of the condition.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
On March 11, Pharmac’s clinical lead of medicines management Melissa Copland confirmed funding from April 1.
6
New Zealand:
On March 11, Pharmac’s clinical lead of medicines management Melissa Copland confirmed funding from April 1.
6